TuHURA Biosciences, Inc./NV financial data

Symbol
HURA on Nasdaq
Location
Tampa, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 146% % -30%
Debt-to-equity 56% %
Return On Equity -193% % -150%
Return On Assets -123% % 59%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51,258,085 shares
Common Stock, Shares, Outstanding 51,254,789 shares 22%
Entity Public Float $14,932,000 USD
Common Stock, Value, Issued $51,255 USD 2463%
Weighted Average Number of Shares Outstanding, Basic 50,666,430 shares 316%
Weighted Average Number of Shares Outstanding, Diluted 50,666,430 shares 316%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD
Research and Development Expense $18,453,675 USD 95%
General and Administrative Expense $10,863,694 USD 210%
Nonoperating Income (Expense) $179,000 USD 85%
Net Income (Loss) Attributable to Parent $29,286,473 USD -75%
Earnings Per Share, Basic 0 USD/shares 79%
Earnings Per Share, Diluted 0 USD/shares 74%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,697,416 USD -11%
Other Assets, Current $806,429 USD
Assets, Current $3,503,845 USD 0.6%
Property, Plant and Equipment, Net $295,332 USD -55%
Operating Lease, Right-of-Use Asset $82,707 USD
Goodwill $13,554,164 USD
Other Assets, Noncurrent $33,769 USD
Assets $25,697,048 USD 521%
Accounts Payable, Current $4,127,968 USD 121%
Accrued Liabilities, Current $1,213,856 USD 261%
Liabilities, Current $8,834,104 USD 291%
Operating Lease, Liability, Noncurrent $42,698 USD
Other Liabilities, Noncurrent $84,985 USD
Liabilities $8,919,089 USD 265%
Accumulated Other Comprehensive Income (Loss), Net of Tax $21,000 USD 0%
Retained Earnings (Accumulated Deficit) $134,421,497 USD 17%
Stockholders' Equity Attributable to Parent $16,777,959 USD
Liabilities and Equity $25,697,048 USD 521%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,738,422 USD -24%
Net Cash Provided by (Used in) Financing Activities $547,878 USD -112%
Net Cash Provided by (Used in) Investing Activities $1,151,047 USD
Common Stock, Shares Authorized 200,000,000 shares 167%
Common Stock, Shares, Issued 51,254,789 shares 3124%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $6,437,347 USD -908%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,697,416 USD -86%
Deferred Tax Assets, Valuation Allowance $46,494,883 USD 118%
Deferred Tax Assets, Gross $46,546,057 USD 118%
Depreciation $68,000 USD -28%
Payments to Acquire Property, Plant, and Equipment $42,672 USD
Property, Plant and Equipment, Gross $2,431,500 USD
Operating Lease, Liability, Current $84,346 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two $43,411 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $43,411 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards $25,098,126 USD 125%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Operating Lease, Payments $43,000 USD 30%
Depreciation, Depletion and Amortization $14,058 USD -59%
Deferred Tax Assets, Net of Valuation Allowance $51,174 USD -22%
Share-based Payment Arrangement, Expense $1,424,736 USD 326%
Interest Expense $16,532 USD -99%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%